Illustrative image – not actual.Gland Pharma is reportedly planning
to set up a new company, Questar Bio-Informatics Ltd (QBL), with an
investment of Rs.15 crore, for venturing into the bio-informatics sector.
Gland Pharma is a 23-year old biotech and pharmaceutical research company owned by Indian, German and Hong Kong-based promoters. The company is a pioneer in the manufacture of injectables such as Heparin.
QBL’s debt-equity ratio would be 40:60. This would be partly funded through equity of Rs.9 crore to be brought in by Gland Pharma. The rest of the funds (Rs.6 crore) would be obtained from the Technology Development Board or through financial institutions.
QBL’s focus area would be ovarian cancer.
The company’s long-term goal would include building databases and developing
specialist manpower in the bio-informatics sector. The company plans to develop
a technology for acquiring, analysing and managing complex genetic information
for the pharmaceutical and life sciences business. The key areas of work would include
drug target discovery, design and medical diagnostics.
